FOSUN HEALTH Logo

Carotid & Intracranial Stenosis Causes

catalogue

Carotid & Intracranial Stenosis Causes

Carotid & Intracranial Stenosis Causes

Both of the narrowings on this page are atherosclerosis, and atherosclerosis is a process with a small number of drivers: pressure, lipids, sugar, smoke, and time. What varies between patients is not usually which of those is present but where the plaque chooses to settle, because the carotid bifurcation and the intracranial arteries are not equally susceptible in every population. This page is about the process, about the handful of things known to drive it, and about the two other conditions that narrow these arteries and are managed differently.

What atherosclerosis does to an artery

Plaque begins in the inner lining of the vessel. Lipid particles enter the wall, the body's cleanup cells take them up and stay, and a slow inflammatory process builds a lesion between the lining and the muscular layer. It grows outward into the wall at first, which is why a substantial plaque can exist before it narrows the channel at all. Later it grows inward and the channel narrows.

Two consequences follow, and they do not track each other, which is the reason a percentage on a report is not the whole story. The channel narrows, so flow can fall short of what the tissue needs. And the surface can become irregular and shed material downstream. A patient can have one without the other, and the second is what produces most of the events.

The lesion also changes character over time. It can calcify and become stable; it can develop a large lipid core under a thin cap; it can bleed into itself; and its surface can ulcerate. These are the features that imaging of the plaque looks for, and they are why the same percentage can sit in front of two different risks.

The drivers, in the order they matter

High blood pressure is the most consistently identified contributor to both carotid and intracranial disease, and it is also the one most often undertreated — controlled to a number that was a target two decades ago rather than to the one that applies now. It acts mechanically, by loading the vessel wall, and it accelerates the process everywhere in the circulation at once.

Smoking acts on the wall and on the blood at the same time: on the lining directly, and on how readily the blood clots. It is the single change with the largest effect and the one most often left for the patient to achieve alone. Former smokers carry more risk than people who never smoked, and the risk falls progressively after stopping rather than returning to baseline at once.

Diabetes accelerates atherosclerosis and shifts where it settles, towards the intracranial vessels and towards more diffuse disease. Raised low-density lipoprotein cholesterol is the substrate the plaque is built from, and it is treated to a target rather than to a dose. Age is the largest single determinant, because the process takes decades. And established vascular disease elsewhere — coronary disease, peripheral arterial disease, or a previous stroke — means the process is already underway in this patient.

Chronic kidney disease belongs on the list for two reasons: it accelerates atherosclerosis, and it changes which investigations and which contrast agents can be used safely.

Why it settles inside the skull in some populations

Where atherosclerosis lands is not random, and it is not the same distribution everywhere. In European populations, stroke from large-vessel disease has historically been attributed more often to the extracranial carotid. In East Asian, South Asian, African and Hispanic populations, intracranial stenosis accounts for a larger share of stroke from large-vessel disease. The same process, a different distribution.

Two things are worth taking from that. The first is practical: a patient from a population in which intracranial disease predominates, who is investigated only for carotid disease, may have the relevant vessel examined last or not at all. The second is that the difference is one of proportion, not of exclusivity — intracranial disease occurs in European populations and carotid disease occurs in East Asian ones, and neither pattern is a reason to stop looking at the other site.

What lies behind the difference is not settled as a single explanation. It has been attributed to differences in the prevalence and control of the drivers listed above, to differences in vessel size and anatomy, and to genetic susceptibility, and the honest answer is that it is probably several of these at once. What is settled is that it matters for which vessel gets looked at first.

Other things that narrow these arteries

Two conditions produce a narrowing in the same vessels and are managed differently enough that recognising them matters.

Radiotherapy to the neck, given for a cancer years earlier, produces carotid narrowing that is often more extensive than typical atherosclerotic disease and located atypically, sometimes involving the common carotid rather than the bifurcation. The skin changes and the history are the clue. These patients tend to be younger at presentation than their atherosclerosis would suggest, and the disease is often bilateral.

Arterial dissection is a tear in the wall of the artery, typically in a younger patient, often after trauma to the neck or sometimes without a clear trigger, and it produces a narrowing or an occlusion with a very different time course. Many dissections heal. It is a separate illness with its own management, and it is mentioned here so that a young patient with a carotid narrowing is not assumed to have atherosclerosis.

Moyamoya disease narrows and closes the terminal carotid and is progressive and non-atherosclerotic, occurring in children and adults. Fibromuscular dysplasia produces a characteristic beaded appearance in the renal and carotid arteries, mostly in women. Both are their own conditions, and both are referred on rather than treated as stenosis.

What does not cause it

A stressful period. Stress is worth treating for its own reasons and because it affects blood pressure, but a narrowing develops over decades and is not produced by a difficult year. Patients often look for a recent event to attribute it to, and the search is usually both fruitless and self-blaming.

A particular food, or cholesterol in the diet alone. Dietary cholesterol is a smaller contributor than the pattern of the whole diet and than the drivers listed above.

Turning the head, or a neck manipulation. This is worth stating precisely, because there is a real thing behind the worry: neck manipulation has been reported as a cause of arterial dissection, which is a different condition and a genuine risk. It does not cause atherosclerotic stenosis. Conflating the two produces both false reassurance and false alarm.

Getting older in itself. Age is the largest determinant in the sense that the process needs time, but it is not the mechanism. Patients in their eighties without these drivers have less disease than patients in their fifties with several of them.

What to do with the list

The list is short enough to act on, and the order is not the order of difficulty. Blood pressure is the one most often undertreated and the one most easily checked — a patient can know their own numbers before an appointment, and the readings taken at home over a week are more useful than a single value taken in a clinic.

Smoking is the largest single change available and the one where support rather than advice is what works. Lipids are treated to a target, which means the question to ask is what the level is and what it should be, not whether a dose has been prescribed. Diabetes, where present, is treated as part of the same plan rather than separately. And all of it applies to a patient who has already had a procedure as much as to one who has not.

Where a patient has several of these, the useful next step is a vascular review rather than a series of separate appointments — one plan covering the carotid, the coronary circulation and the risk factors, with targets and dates.

Frequently Asked Questions

Is it hereditary?

Partly, and more as susceptibility than as destiny. A family history of early stroke or vascular disease raises the likelihood, and the inherited contribution to blood pressure, lipids and diabetes is substantial, so what runs in families is often the drivers rather than the narrowing itself. Specific single-gene causes of stroke exist but are rare and are not the explanation for a typical carotid or intracranial stenosis. What is worth doing with a family history is acting on it earlier: knowing and treating blood pressure and lipids before they have had decades to work.

Can it be reversed?

The narrowing itself is not usually expected to disappear. What does change is the risk it carries and the rate at which the underlying process proceeds: statin therapy to a target stabilises plaque and in some studies is associated with regression of the plaque volume, and stopping smoking and controlling blood pressure and diabetes slow the process throughout the circulation. Thinking of it as reversal sets up a scan to disappoint; thinking of it as risk reduction is both accurate and the reason the treatment is worth taking.

I had radiotherapy to the neck years ago. Does that change things?

Yes, and it is worth telling every clinician who looks at your imaging. Radiation-associated carotid disease tends to be more extensive than typical atherosclerosis, is often located atypically along the common carotid rather than at the bifurcation, and can present at a younger age. It can also make surgery technically more difficult, because the tissues in the neck have been irradiated. The surveillance for it starts on the basis of the history rather than on symptoms.

Why did I get this when I look after myself?

Because the drivers are not the whole story and because the process takes decades. Age, inherited susceptibility to blood pressure and lipids, and exposure that ended years ago all contribute, and a person can carry significant disease while doing everything currently asked of them. It is also common for a patient's blood pressure or lipids to have been uninteresting by the standards of twenty years ago and to be above target by current ones. The question worth asking now is what the targets are and how they are being met, rather than what caused it.

Bring the numbers, not only the scan

Tell us the blood pressure readings taken at home over a week rather than one value from clinic, the most recent lipid panel with the target that was set, whether diabetes is present, and whether the patient smokes or has smoked. Send the imaging report with the method of measurement. A neurovascular specialist will return a written opinion within about 48 hours of complete records arriving: what is driving this in this patient, what the targets should be, and what the follow-up should contain.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*